Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Health

nitpicked

(1,804 posts)

2. Understanding GLP-1 Drugs: Cost, Safety, and Access in Context

Reply to niyad (Reply #1)

Wed Mar 18, 2026, 03:32 PM

Mar 18

https://nam.edu/news-and-insights/understanding-glp-1-drugs/

(snip)

GLP-1 receptor agonists (GLP-1s)—better known by brand names Ozempic, Wegovy, Mounjaro, or Zepbound— are often referred to as “miracle drugs.” GLP-1s were originally developed to help regulate blood sugar in people with type 2 diabetes. They also contribute to substantial weight loss for people with obesity and show promise in helping to manage other conditions, such as cardiovascular disease and substance use disorder.
(snip)

Edit history

Please sign in to view edit histories.

Recommendations

1 members have recommended this reply (displayed in chronological order):

kcoates

5 replies

= new reply since forum marked as read

Highlight:

Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says [View all] nitpicked Mar 18 OP

Having read the article, WHAT are glp-1's? niyad Mar 18 #1

Understanding GLP-1 Drugs: Cost, Safety, and Access in Context nitpicked Mar 18 #2

"in patients with Type 2 diabetes" hedda_foil Mar 18 #3

This is an important medical study, but the way the stats are presented makes my brain pop Ilikepurple Mar 18 #4

Is that because the patients put weight on and ate less healthy after stopping GLP-1? Doodley Mar 18 #5